Compare STEM to:
Real-Time: 1.05 -0.02 (-1.87%) 3:37pm ET
| Last Trade: | 1.05 |
|---|---|
| Trade Time: | 3:23pm ET |
| Change: | |
| Prev Close: | 1.07 |
| Open: | 1.09 |
| Bid: | 1.04 x 35100 |
| Ask: | 1.05 x 2600 |
| 1y Target Est: | 3.00 |
| Day's Range: | 1.03 - 1.10 |
|---|---|
| 52wk Range: | 0.89 - 3.07 |
| Volume: | 1,369,888 |
| Avg Vol (3m): | 1,345,630 |
| Market Cap: | 124.27M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.32 |
| Div & Yield: | N/A (N/A) |
| Mon, Nov 23 | StemCells, Inc. CEO Martin McGlynn Featured On BioBusiness.TV's "Stem Cell Review" SeriesBusiness Wire |
| Mon, Nov 23 | StemCells, Inc. Initiates Landmark Trial Targeting "Communication Highway" of the BrainBusiness Wire |
| Fri, Nov 20 | STEMCELLS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online |
| Wed, Nov 18 | StemCells, Inc. Provides Update on NCL Program Meeting with FDABusiness Wire |
| Thu, Nov 12 | Trading Outlook for StemCells Inc. Issued by InvestorSoup.comGlobeNewswire |
| Wed, Nov 11 | Can Stem Cells Put an End To Paralysis?Indie Research |
| Tue, Nov 10 | STEMCELLS INC FinancialsEDGAR Online Financials |
| Sun, Nov 8 | New Star Analyst Rankings for StemCells, Inc.StarMine |
| Thu, Nov 5 | STEMCELLS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online |
| Thu, Nov 5 | StemCells reports Q3 loss of $5Mat bizjournals.com |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.